iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Principle Wealth Partners LLC

Principle Wealth Partners LLC decreased its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 5.3% in the fourth quarter, HoldingsChannel reports. The firm owned 5,705 shares of the financial services provider’s stock after selling 322 shares during the quarter. Principle Wealth Partners LLC’s holdings in iShares Biotechnology ETF were worth $754,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. BNP Paribas Financial Markets lifted its holdings in iShares Biotechnology ETF by 29.3% in the third quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock valued at $346,561,000 after acquiring an additional 538,899 shares during the period. Healthcare of Ontario Pension Plan Trust Fund lifted its holdings in iShares Biotechnology ETF by 32.9% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after acquiring an additional 164,000 shares during the period. Aprio Wealth Management LLC acquired a new position in iShares Biotechnology ETF in the fourth quarter valued at approximately $18,476,000. DRW Securities LLC acquired a new position in iShares Biotechnology ETF in the third quarter valued at approximately $5,990,000. Finally, Erste Asset Management GmbH acquired a new position in iShares Biotechnology ETF in the third quarter valued at approximately $5,678,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ:IBB opened at $134.24 on Wednesday. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57. The business has a 50 day moving average of $135.99 and a two-hundred day moving average of $141.17.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were given a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.